After months of anticipation, the Canadian government has given its approval for cannabis to be sold in the country: officially making Canada the largest country in the world to legalize the plant. However, while the decision itself is a step in the right direction, there is still a lot of work to do. The government wants to make sure that the drug will be regulated, but it must also convince the public that it is safe. Once these issues are addressed, the government will have all the components it needs to legalize the drug.
This week, a few small-cap marijuana stocks got a nice boost, as momentum traders began to realize weed stocks could see a huge run. The big news was the approval of the Canada-EU trade deal, which now allows for the importation of cannabis products from Europe. This was expected, as Canada already has a robust cannabis industry, and the EU has a lot of things that can be sold to Canadians.
The cannabis market has seen a lot of activity in the past few weeks, perhaps a bit of an over-correction after a run-up in prices that began in late May. The stock market overall has seen a strong week, with major indices holding flat or even gaining ground. Will the market continue to hold, or will it go back down?. Read more about bgcang news and let us know what you think.
Navigate the evolving cannabis industry with 420 Investor, a premium service that sends you real-time alerts and explanations of the news below and more.
Connecticut came close, but ultimately failed to pass an adult use law.
Health Canada has added 12 licences, bringing the total number of licences to 692.
Over the past year, 420 Investor’s model portfolios have increased 56.2% to 90.2%, while the Global Cannabis Stock Index has increased 33.7%.
Overview Connecticut lawmakers missed the deadline, but will meet in special session to continue their efforts to legalize cannabis for adult use. Health Canada added 12 new licences, bringing the total number of licences to 692, including 4 expired, revoked or suspended licences. I shared this information with 420 subscribers of Investor this week:
Composition of the model portfolio 06/04/21
Cannabis Subsector Review – 06/04/21
First look at the MSO Ascend Wellness, which focuses on the essentials.
Preliminary overview of Fire & Flower’s first quarter financial results.
Here are some of the most notable names on this week’s 420 Investor Focus List:
ACB has marketed three of its own varieties under the San Rafael ’71 label.
CFSF completed the acquisition of Green Leaf for $240 million, expanding its operations in Maryland, Ohio, Pennsylvania and Virginia. The company also launched an online search tool, Forage, to simplify and personalize the online shopping experience.
CGC moves closer to acquiring Supreme Cannabis after shareholder approval
CRLBF has expanded its Good News brand into the adult markets in California, Illinois and Michigan with its first CBN product, as well as other dietary supplements.
CURLF has announced a partnership with Rolling Stone to launch Preroll Select and a new capsule system, The Cliq, each with three flavors and flavor profiles.
GDNSF has changed its name from Vireo Health to Goodness Growth Holdings. The company gave a revenue guidance of $140 million to $180 million and adjusted EBITDA of $35 million to $55 million for 2022. The company will also engage in research and development of intellectual property in the field of psychedelics.
GRWG announced that its patented Power-Si silica is now distributed through a partner in Canada. Three insiders sold more than $20 million worth of shares.
GTBIF shares ($1.667 million) held by a CEO-controlled private equity firm were sold for $30 to the company’s new institutional investor.
HBORF settles 2018 lawsuit, pays $1.5 million in settlement agreement with ex-employee
PLNHF reported sales of $11.2 million in May and a gross margin of more than 50%.
SMG has funded several social justice organizations through its Hawthorne Fund for Social Justice.
TCNNF completed the acquisition of Solevo Wellness West Virginia for $650,000 with three additional dispensary licenses. The company has launched Refined Cream, a new premium cannabis concentrate made by cold ethanol extraction. The company opened a clinic in Tampa, its 83rd in Florida.
TLLTF will receive an upfront payment of Blackbird’s outstanding debt in connection with the acquisition.
TLRY has launched a new medicinal cannabis brand, Symbios, which focuses on lower prices for a wider range of formats and a unique cannabinoid ratio.
The Global Cannabis Value Index was little changed this week, rising 0.4% to 59.34 : Theindex, which lost 34.1 percent in 2019 and 54.9 percent in 2018 after rising 91.8 percent in 2017 and 88.8 percent in 2016, rose 5.2 percent in 2020. For 2021, the price has increased by 33.7%. It currently has 46 shares and ended 2020 at 44.39 : Examples of portfolios 420 Investor offers subscribers three model portfolios, two of which are long-term and fully invested to beat the Global Cannabis Stock Index, 420 Opportunity and 420 Quality. 420 Opportunity ended the week with an estimate of $175,740, up 0.4%. The model portfolio has increased by 66.8% in 2021, 35.6% in 2020 and 251.5% since April 2014. 420 Quality ended the week at $252,208, up 0.3% for the week and now up 56.2% in 2021 after up 42.8% in 2020. Launched in March 2017, the model is designed for long-term investors looking to invest in leading cannabis stocks with low portfolio turnover. Since its inception, it has gained 404.4%, compared to an index decline of 26.6%. Flying High, which focuses on swing trading, ended the week at $480,176, up 0.4%. The model portfolio is up 52.7% in 2020 and 90.2% in 2021, with a return of 4702% since inception at the end of 2013. Outlook After a strong recovery in early 2019, the cannabis sector fell sharply to unprecedented levels the following year due to several negative events, including the CannTrust scam, the unexpected resignation of Bruce Linton as CEO of Canopy Growth, the disappointing start to legalization in Canada, confusion over CBD regulation in the US and the slow start to legalization in California, the vaping crisis, and then the financial turmoil and market disruption caused by the COVID-19 pandemic. In the industry, the capital available to fund expansion has dried up, a situation that continues to put heavy pressure on companies with negative cash flow, as the availability of capital is constrained by stronger market participants. Cannabis stocks overreacted and reached their bottom in March 2020. Today they benefit from the perception that the sector offers good growth prospects, which was not the case then. One important change is that the pandemic has forced many regulators to ban previously prohibited retail activities, such as B. to allow home pickup and delivery. The legal market is growing rapidly and is becoming even more convenient than the illegal market because orders can be placed online. High unemployment and large deficits have fueled states’ legalization efforts, as well as more favorable regulatory controls at the local level. Access to capital has improved dramatically and large companies are generating significant and rapidly growing revenues and profits. There are several potential catalysts, including the FDA providing clarity on CBD regulation, the progress of legalization in Canada that began in October 2018 and is gradually covering a wider range of products, and the continued growth of German and Israeli MMJ and other international markets that have been slow to develop. Implementation in California and Massachusetts for adults has been slow, but there are already significant improvements. Michigan and Illinois legalized adult-use drugs in late 2019, and those markets are showing strong growth that could prompt other states to legalize. Voters in Arizona, Montana, South Dakota and New Jersey approved adult drug legalization in November, and New Mexico, New York and Virginia introduced legalization in the legislature in 2021. Key issues for the future are likely to include continued cross-sector investment in the sector and further consolidation in Canada and the US, potential reform of federal regulations (SAFE Banking Act and other broader legislation that could lift the 280E tax and allow OMCs to trade on higher exchanges, as well as the widespread use of credit cards to purchase cannabis), measures to enable cannabis research, the introduction of MMJ in Germany, Mexico and Australia, and continued progress in South America and the potential of the cannabis industry. Stay ahead of the crowd by subscribing to 420 Investor, the largest and most comprehensive subscription service for cannabis dealers and investors since 2013. Based in Houston, Alan draws on his experience as founder of the 420 Investor online community, the first and still largest integrated analysis platform focused on publicly traded cannabis stocks. Through his many connections in the cannabis community, Alan continues to find new ways to bring the industry together and promote sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Until early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent analyst and then for more than two decades in research and portfolio management. Alan is a prolific writer with over 650 articles published on Seeking Alpha since 2007, where he has 70,000 subscribers. He is a frequent speaker at industry conferences and appears regularly in the media, including the NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Get in touch with Alan: Twitter | Facebook | LinkedIn | E-mail
Columbia Care completes acquisition of Green Leaf for $240 million
Harborside Inc. announces settlement ofclaims
Cresco Labs diversifies edible and narcotics portfolio with good newsBrand expansion
Vireo Health expects sales of $140 million to $180 million in 2022 and is adopting a new name:.
Stock prices soared on Monday, after a Canadian cannabis company agreed to be the first to sell its share of produce through a major retailer.. Read more about 420 investor complaints and let us know what you think.